ACIU Total Current Assets from 2010 to 2025
| ACIU Stock | USD 3.99 0.86 27.48% |
Total Current Assets | First Reported 2014-12-31 | Previous Quarter 152.1 M | Current Value 131.8 M | Quarterly Volatility 76 M |
Check AC Immune financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AC Immune's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Interest Expense of 126.3 K or Selling General Administrative of 8.7 M, as well as many indicators such as Price To Sales Ratio of 8.5, Dividend Yield of 0.0 or PTB Ratio of 2.07. ACIU financial statements analysis is a perfect complement when working with AC Immune Valuation or Volatility modules.
ACIU | Total Current Assets | Build AI portfolio with ACIU Stock |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for ACIU Stock Analysis
When running AC Immune's price analysis, check to measure AC Immune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AC Immune is operating at the current time. Most of AC Immune's value examination focuses on studying past and present price action to predict the probability of AC Immune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AC Immune's price. Additionally, you may evaluate how the addition of AC Immune to your portfolios can decrease your overall portfolio volatility.